Literature DB >> 19822285

Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.

Andrea S Wolf1, Jonathan Daniel, David J Sugarbaker.   

Abstract

Trimodality treatment of malignant pleural mesothelioma with cytoreductive surgery followed by radiation and chemotherapy has resulted in long-term survival for a select group of patients. Knowledge of the similarities and differences between the two operations that have evolved-extrapleural pneumonectomy and pleurectomy/decortication-is prerequisite to understanding the complex issues associated with patient selection, diagnosis, pathologic staging, preoperative assessment, perioperative management, and adjuvant treatment. Both operations are technically complex and should only be performed at experienced high-volume centers.

Entities:  

Mesh:

Year:  2009        PMID: 19822285     DOI: 10.1053/j.semtcvs.2009.07.007

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  15 in total

1.  Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery.

Authors:  K Annette Mizuguchi; Aya Mitani; Sushrut S Waikar; Peter Ireland; Christia Panizales; Gretchen Deluke; David J Sugarbaker; Joseph V Bonventre; Gyorgy Frendl
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 8.237

2.  Standardizing surgical treatment in malignant pleural mesothelioma.

Authors:  David Rice
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 3.  Overview of treatment related complications in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

Review 4.  Malignant pleural mesothelioma.

Authors:  Siva Raja; Sudish C Murthy; David P Mason
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

Review 5.  A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).

Authors:  Jo Raskin; Veerle Surmont; Robin Cornelissen; Paul Baas; Paul E Y van Schil; Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2018-10

6.  Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Yusuke Itani; Satoshi Mabuchi; Norihiko Kodama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2017-03-14       Impact factor: 3.603

7.  Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.

Authors:  Andrea Bille; Elizabeth Belcher; Hilgard Raubenheimer; David Landau; Paul Cane; James Spicer; Loïc Lang-Lazdunski
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

8.  Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.

Authors:  Daniel R Gomez; David S Hong; Pamela K Allen; James S Welsh; Reza J Mehran; Anne S Tsao; Zhongxing Liao; Stephen D Bilton; Ritsuko Komaki; David C Rice
Journal:  J Thorac Oncol       Date:  2013-02       Impact factor: 15.609

Review 9.  Current surgical strategies for malignant pleural mesothelioma.

Authors:  Teruhisa Takuwa; Seiki Hasegawa
Journal:  Surg Today       Date:  2015-11-21       Impact factor: 2.549

10.  Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.

Authors:  Kwan-Chang Kim; Hong-Phuc Vo
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.